A clinical,renal and immunological assessment of Surface Modifying Additive Treated (SMART™) cardiopulmonary bypass circuits

Abstract

Biocompatible cardiopulmonary bypass (CPB) circuits aim to reduce contact activation and its physiological consequences. We investigated the hypothesis that use of Surface Modifying Additive (SMA)-treated circuits (Sorin Group Ltd) compared with non-SMA circuits would be associated with preservation of blood pressure during CPB and modulation of perioperative subclinical renal function (urinary α-1-microglobulin (α-1-m)) and plasma and urinary cytokine changes. In a study of low-risk CABG patients (n=40), randomized to SMA (n=20) versus non-SMA circuits (n=20), we found better preserved blood pressure at CPB initiation in SMA patients (p <0.05), particularly in ACE-inhibited SMA patients (n=11) versus ACE-inhibited non-SMA patients (n=10) (p <0.05). Plasma anti-inflammatory IL-10, as well as urinary α-1-m, were elevated 48 hours postoperatively (p <0.05). SMA patients also had lower blood loss (p <0.05). SMA circuits have some clinical benefit, especially in ACE-inhibited patients.

Get full access to this article

View all access options for this article.

References

Gormley SM , Armstrong MA , McMurray TJ , McBride WT. The effect of methylprednisolone on cytokine concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system . Cytokine 2003; 22: 149-155 .

Bedi A , McBride WT , Armstrong MA , Murray JM , Fee JP. Xenon has no effect on cytokine balance and adhesion molecule expression within an isolated cardiopulmonary bypass system . Br J Anaesth 2002; 89: 546-550 .

Gormley SM , McBride WT , Armstrong MA , et al. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass . Cytokine 2002; 17: 61-65 .

McBride WT , Armstrong MA , Crockard AD , McMurray TJ , Rea JM. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits . Br J Anaesth 1995; 75: 724-733 .

Wan S , LeClerc JL , Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies . Chest 1997; 112: 676-692 .

McBride WT , Armstrong MA , McBride SJ. Immuno-modulation: an important concept in modern anaesthesia . Anaesthesia 1996; 51: 465-473 .

Laffey JG , Boylan JF , Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist . Anesthesiology 2002; 97: 215-252 .

McBride WT , Armstrong MA , Gilliland H , McMurray TJ. The balance of pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery . Cytokine 1996; 8: 724-729 .

McBride WT , Allen S , Gormley SM et al. Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery . Cytokine 2004; 27: 81-89 .

10.

Gormley SM , McBride WT , Armstrong MA et al. Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery . Anesthesiology 2000; 93: 1210-1216 .

11.

Baker RC , Armstrong MA , Allen SJ , McBride WT. Role of the kidney in perioperative inflammatory responses . Br J Anaesth 2002; 88: 330-334 .

12.

Westhuyzen J , McGiffin DC , McCarthy J , Fleming SJ. Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass . Clin Chim Acta 1994; 228: 123-132 .

13.

Boldt J , Brenner T , Lang J , Kumle B , Isgro F. Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass . Anesth Analg 2003; 97: 1582-1589 .

14.

Price RG. Urinalysis to exclude and monitor nephrotoxicity . Clinica Chimica Acta 2000; 297: 173-182 .

15.

Cugno M , Nussberger J , Biglioli P , Giovagnoni MG , Gardinali M , Agostoni A. Cardiopulmonary bypass increases plasma bradykinin concentrations . Immuno-pharmacology 1999; 43: 145-147 .

16.

Campbell DJ , Dixon B , Kladis A , Kemme M , Santa-maria JD. Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans . Am J Physiol Regul Integr Comp Physiol 2001; 281: R1059-R1070 .

17.

Tsai CC , Deppisch RM , Forrestal LJ et al. Surface modifying additives for improved device-blood compatibility . Asaio J 1994; 40: 619-624 .

18.

Tang L , Sheu MS , Chu T , Huang YH. Anti-inflamma-tory properties of triblock siloxane copolymer-blended materials . Biomaterials 1999; 20: 1365-1370 .

19.

Bhujle R , Li J , Shastri P et al. Influence of cardiopulmonary bypass on platelet and neutrophil accumulations in internal organs . Asaio J 1997; 43(5): M739-M744 .

20.

Gu YJ , Boonstra PW , Rijnsburger AA , Haan J , van Oeveren W. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility . Ann Thorac Surg 1998; 65: 1342-1347 .

21.

Rubens FD , Labow RS , Lavallee GR et al. Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block copolymer . Ann Thorac Surg 1999; 67: 689-696 .

22.

Defraigne JO , Pincemail J , Dekoster G et al. SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery . Ann Thorac Surg 2000; 70: 2075-2081 .

23.

Brodbeck WG , Voskerician G , Ziats NP , Nakayama Y , Matsuda T , Anderson JM. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry . J Biomed Mater Res 2003; 64A: 320-329 .

24.

Deng J , Kohda Y , Chiao H et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury . Kidney Int 2001; 60: 2118-2128 .

25.

Rubens FD , Ruel M , Lavallee G et al. Circuits with surface modifying additive alter the haemodynamic response to cardiopulmonary bypass . Eur J Cardiothorac Surg 1999; 15: 353-358 .

26.

Isgro F , Kiessling AH , Mittelstaedt H , Saggau W.

Surface modification of extracorporeal circuits: is there really an impact on cerebral performance after cardio-pulmonary bypass?

Thorac Cardiovasc Surg 2001; 49: 65-69 .

27.

Frangogiannis NG. Myocardial hibernation. Clinical and pathological perspectives . Minerva Cardioangiol 2003; 51: 261-274 .

28.

Grone HJ , Warnecke E , Olbricht CJ. Characteristics of renal tubular atrophy in experimental renovascular hypertension: a model of kidney hibernation . Nephron 1996; 72: 243-252 .

29.

Akerstrom B , Logdberg L , Berggard T , Osmark P , Lindqvist A. a-1-Microglobulin: a yellow brown lipocalin . Biochim Biophys Acta 2000; 1482: 172-184 .

30.

Pierzchalski P , Rokita H , Koj A , Fries E , Akerstrom B. Synthesis of alpha-1-microglobulin in cultured rat hepatocytes is stimulated by interleukin-6, leukaemia inhibitory factor, dexamethasone and retinoic acid . FEBS Lett 1992; 298: 165-168 .